It was announced today that Teva Pharmaceutical Industries will be acquiring IVAX for $7.4 billion. IVAX shares will be converted to either $26 in cash or 0.8471 TEVA ADRs. The boards of directors of both companies have given their approval. IVAX shareholders are expected to own about 15% of TEVA on a fully-diluted basis as a result of the transaction.
latest ebusiness news. 
No comments yet. Be the first to comment!